HUT71768A - Interferon regulatory factors 1 and 2 in the diagnosis of tumorogenicity - Google Patents

Interferon regulatory factors 1 and 2 in the diagnosis of tumorogenicity

Info

Publication number
HUT71768A
HUT71768A HU9500841A HU9500841A HUT71768A HU T71768 A HUT71768 A HU T71768A HU 9500841 A HU9500841 A HU 9500841A HU 9500841 A HU9500841 A HU 9500841A HU T71768 A HUT71768 A HU T71768A
Authority
HU
Hungary
Prior art keywords
tumorogenicity
diagnosis
regulatory factors
interferon regulatory
interferon
Prior art date
Application number
HU9500841A
Other languages
English (en)
Other versions
HU217688B (hu
HU9500841D0 (en
Inventor
Tadatsugu Taniguchi
Cheryl L Willman
Maria G Pallavicini
Hisashi Harada
Nobuyuki Tanaka
Original Assignee
Univ California
Taniguchi
Univ New Mexico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Taniguchi, Univ New Mexico filed Critical Univ California
Publication of HU9500841D0 publication Critical patent/HU9500841D0/hu
Publication of HUT71768A publication Critical patent/HUT71768A/hu
Publication of HU217688B publication Critical patent/HU217688B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9500841A 1992-09-24 1993-09-24 Interferon regulátor faktor 1 és 2 a tumorigenitás diagnózisában HU217688B (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95057492A 1992-09-24 1992-09-24
US99559492A 1992-12-22 1992-12-22
PCT/US1993/009185 WO1994006818A1 (en) 1992-09-24 1993-09-24 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity

Publications (3)

Publication Number Publication Date
HU9500841D0 HU9500841D0 (en) 1995-05-29
HUT71768A true HUT71768A (en) 1996-01-29
HU217688B HU217688B (hu) 2000-03-28

Family

ID=27130304

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9500841A HU217688B (hu) 1992-09-24 1993-09-24 Interferon regulátor faktor 1 és 2 a tumorigenitás diagnózisában

Country Status (10)

Country Link
US (2) US5652095A (hu)
EP (1) EP0662976A4 (hu)
JP (1) JPH08501691A (hu)
CN (1) CN1051110C (hu)
AU (1) AU682321B2 (hu)
CA (1) CA2145412A1 (hu)
HU (1) HU217688B (hu)
MX (1) MX9305855A (hu)
NZ (1) NZ256623A (hu)
WO (1) WO1994006818A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605712B1 (en) * 1990-12-20 2003-08-12 Arch Development Corporation Gene transcription and ionizing radiation: methods and compositions
EP0648493A1 (en) * 1993-10-19 1995-04-19 Tadatsugu Prof. Dr. Taniguchi A method to reverse the phenotype of transformed cells by the transcription factor IRF-1
PH31414A (en) * 1994-02-24 1998-10-29 Boehringer Ingelheim Int Method of diagnosing cancer precancerous state, orsusceptibility to other forms of diseases by anal ysis of irf-1 specific rna in biopsy samples.
JP2001523103A (ja) * 1997-04-28 2001-11-20 ローヌ−プーラン・ロレ・エス・アー 腫瘍治療用血管形成アンタゴニストのアデノウイルスによる腫瘍内送達
EP1213028B1 (en) 1999-08-23 2008-08-13 Chugai Seiyaku Kabushiki Kaisha Hm1.24 antigen expression potentiators
EP1364657B1 (en) 2001-02-07 2016-12-28 Chugai Seiyaku Kabushiki Kaisha Remedies for myelocytic leukemia
JP4522431B2 (ja) * 2001-02-07 2010-08-11 中外製薬株式会社 造血器腫瘍の治療剤
CA2439335A1 (en) * 2001-02-26 2002-09-06 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf) Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
US20040242523A1 (en) * 2003-03-06 2004-12-02 Ana-Farber Cancer Institue And The Univiersity Of Chicago Chemo-inducible cancer gene therapy
JP2004532213A (ja) * 2001-04-06 2004-10-21 ザ ユニヴァーシティ オヴ シカゴ Ｅｇｒ−１プロモーター活性の化学療法誘導
US8034791B2 (en) 2001-04-06 2011-10-11 The University Of Chicago Activation of Egr-1 promoter by DNA damaging chemotherapeutics
CN108221058A (zh) * 2017-12-29 2018-06-29 苏州金唯智生物科技有限公司 一种猪全基因组sgRNA文库及其构建方法和应用
CN108205614A (zh) * 2017-12-29 2018-06-26 苏州金唯智生物科技有限公司 一种全基因组sgRNA文库的构建系统及其应用
AU2021231880A1 (en) * 2020-03-06 2022-10-06 University Of Pittsburgh - Of The Commonwealth System Of Higher Education IRF modulator-expressing oncolytic viruses for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
DE68915375T2 (de) * 1988-08-24 1994-09-29 Taniguchi Tadatsugu Gen-Expression regulierender Faktor.
CA2104964A1 (en) * 1991-02-28 1992-08-29 Ruth Sager Cancer diagnosis and therapy with tumor suppressor genes

Also Published As

Publication number Publication date
CA2145412A1 (en) 1994-03-31
CN1051110C (zh) 2000-04-05
AU5141793A (en) 1994-04-12
CN1098140A (zh) 1995-02-01
US5807836A (en) 1998-09-15
AU682321B2 (en) 1997-10-02
WO1994006818A1 (en) 1994-03-31
EP0662976A1 (en) 1995-07-19
HU217688B (hu) 2000-03-28
JPH08501691A (ja) 1996-02-27
EP0662976A4 (en) 1997-04-23
HU9500841D0 (en) 1995-05-29
US5652095A (en) 1997-07-29
MX9305855A (es) 1995-01-31
NZ256623A (en) 1997-04-24

Similar Documents

Publication Publication Date Title
GB9202755D0 (en) Platinum complexes and use thereof
EP0469921A3 (en) Deodorant and product in which the deodorant is used
EP0406428A4 (en) Peptide derivatives and their use
ZA939200B (en) DNA-armed ribozymes and minizymes
GB9013410D0 (en) Polypeptide and its use
KR100321237B1 (ko) 적층구조물
HU9500841D0 (en) Interferon regulatory factors 1 and 2 in the diagnosis of tumorogenicity
EP0445801A3 (en) Peptide and its use
EP0482649A3 (en) Cm-chitin derivatives and use thereof
GB9117954D0 (en) Multriaxis robot and use thereof
GB9325297D0 (en) Improvements in or relating to clamps and the use thereof
GB8911294D0 (en) Composition and use
GB9027864D0 (en) Pyrimidinyl-and triazinyl-salicylamides and their use and preparation
NZ237380A (en) 1 hydroxyalkyl-5-nitroimidazoles and their preparation
GB9016027D0 (en) Composition and use
HK1014195A1 (en) Polyamide composition and the use
IL105873A0 (en) Pyrimidinyl-and triazinyl-salicyl-and-picolyl-amides and the use and preparation thereof
EP0540575A4 (en) Human meg-csf protein and methods
ZA937083B (en) Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity
GB9314512D0 (en) Composition and use
IL109356A0 (en) N-substituted-2-azetidinones and their use in the preparation of n-unsubstituted-2-azetidinones
GB2248422B (en) Cheque books and the like
GB9013872D0 (en) Use of protein a and polypeptide components thereof in the treatment of tumours
ZA935430B (en) 5 S penem derivatives their preparation and use
KR950703574A (ko) 종양발생 진단에 있어서의 인터페론 조절 인자 1및 2(Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity)

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee